Lab

Quest Diagnostics was recently granted a breakthrough device designation from the FDA for its adeno-associated virus test. 

The CDC could restructure its lab operations under recent recommendations made by its Laboratory Workgroup.

The CDC plans to overhaul its lab operations after mishaps with its COVID-19 test, KFF Health News reported Aug. 21. 

Three of Orlando (Fla.) Health's laboratories recently received accreditation from the College of American Pathologists.

Quest Diagnostics acquired assets from NewYork-Presbyterian' lab business in an all-cash transaction for $275 million, according to financial documents filed July 27 with the Securities and Exchange Commission. 

The Justice Department filed a complaint against Patrick Britton-Harr and several laboratory companies he owns for allegedly submitting claims to Medicare for tests that were not ordered by providers, not medically necessary and sometimes never performed. 

He Jiankui, PhD, a Chinese scientist who sparked controversy in 2018 after claiming to have genetically modified two human embryos, is on a new scientific endeavor: trying to develop a therapy for Duchenne muscular dystrophy, NPR reported June 8.

On Feb. 24, the FDA issued an emergency use authorization for the first over-the-counter rapid test that can detect both COVID-19 and flu. However, it's unclear when the test might be available to consumers as Lucira Health, the test's developer,…

Quest Diagnostics has agreed to acquire some laboratory services assets from New York City-based NewYork-Presbyterian.

A team of engineers and infectious disease researchers at Washington University in St. Louis developed a new rapid point-of-care diagnostic test that is 1,000 times more sensitive than conventional tests.